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Tyrosine kinase signaling is tightly controlled by
negative feedback inhibitors including suppres-
sors of cytokine signaling (SOCS). SOCS as-
semble as SH2 domain substrate recognition
modules in ElonginB/C-cullin ubiquitin ligases.
In accordance, SOCS4 reduces STAT3 signal-
ing from EGFR through increased receptor deg-
radation. Variable C-termini in SOCS4–SOCS7
exclude these family members from a SOCS2-
type domain arrangement in which a strictly
conserved C terminus determines domain pack-
ing. The structure of the SOCS4-ElonginC-Elon-
ginB complex reveals a distinct SOCS structural
class. The N-terminal ESS helix functionally re-
places the CIS/SOCS1–SOCS3 family C termi-
nus in a distinct SH2-SOCS box interface that
facilitates further interdomain packing between
the extended N- and C-terminal regions charac-
teristic for this subfamily. Using peptide arrays
and calorimetry the STAT3 site in EGFR (pY1092)
was identified as a high affinity SOCS4 substrate
(KD = 0.5 mM) revealing a mechanism for EGFR
degradation. SOCS4 also bound JAK2 and
KIT with lowmicromolar affinity, whereas SOCS2
was specific for GH-receptor.
INTRODUCTION
Secreted cytokines and growth factors modulate the sur-
vival, proliferation, and differentiation of most cell types
through type-specific receptor binding and activation of
intracellular signaling cascades. Ligand-induced receptor
dimerization activates intrinsic receptor tyrosine kinase
(RTK) activity and for most cytokine receptors recruitment
of Janus kinase/signal transducer and activator of tran-
scription (JAK/STAT) (Ihle, 1995). A characteristic feature
of receptor activation is the creation of phosphotyrosine
docking sites for Src-homology 2 (SH2) domain proteins
that modulate the intracellular response (Moran et al.,Structure 15, 1493–151990). The suppressor of cytokine signaling (SOCS) family
was first recognized as a group of cytokine-inducible SH2
(CIS) domain proteins comprising eight family members in
human (CIS and SOCS1–SOCS7) (Hilton et al., 1998; Starr
et al., 1997). The four prototypical members, CIS and
SOCS1–SOCS3, have been studied extensively and in
a classic negative feedback response compete for binding
at phosphotyrosine sites in JAK kinase and receptor path-
ways to displace effector proteins and target bound re-
ceptors for proteasomal degradation (Kile et al., 2002).
Loss of SOCS activity results in excessive cytokine signal-
ing associated with a variety of hematopoietic, autoim-
mune, and inflammatory diseases and certain cancers
(O’Sullivan et al., 2007). Surprisingly, the remaining SOCS
family members SOCS4–SOCS7, which represent the
direct orthologs of ancestral SOCS family genes show
limited cytokine induction, and it is of current interest to
address their role in cytokine suppression and other signal-
ing events.
The absence of a JAK kinase in C. elegans has sug-
gested that its ancestral SOCS gene might fulfill a wider
role regulating receptor tyrosine kinases (Kile et al.,
2002). Several studies have demonstrated SOCS regula-
tion of the epidermal growth factor receptor (EGFR or
ErbB) family (Goldshmit et al., 2004; Kario et al., 2005;
Nicholson et al., 2005; Rawlings et al., 2004; Xia et al.,
2002). EGF signaling is a major determinant of epithelial
cell proliferation, and due to its high oncogenic potential
and incidence in cancer, the EGFR is one of the best
characterized substrates for SH2 interactions (Citri and
Yarden, 2006; Jones et al., 2006; Schulze et al., 2005).
EGFR signaling is mediated either by direct STAT SH2
binding and transactivation or by the SH2 adaptor pro-
teins Grb2 and Shc, which couple to the Ras-MAPK and
Ras-PI3K-AKT/PKB pathways. Additional SH2 domain
proteins confer downregulation, including the SHP1 phos-
phatase and the Cbl ubiquitin ligase, which directs EGFR
degradation. A number of combinatorial control systems
have evolved that lead to EGFR degradation in response
to different stimuli (Citri and Yarden, 2006).
A role for SOCS in EGFR signaling has been suggested
from studies in Drosophila, which presents a simplified
model system with only one JAK, STAT, and EGFR family
member (Arbouzova and Zeidler, 2006). Of the three04, November 2007 ª2007 Elsevier Ltd All rights reserved 1493
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Structure of the SOCS4-ElonginB/C Ternary ComplexDrosophila SOCS genes, only SOCS36E, a close ortholog
of human SOCS4 and SOCS5, has shown prototypical
SOCS negative feedback activity. Transgenic flies overex-
pressing SOCS36E display wing defects that phenocopy
Drosophila mutants of JAK, STAT, and EGFR and are ex-
acerbated in flies heterogeneous for these genes. Con-
versely, the defects are partially rescued by inactivating
one copy of the d-cbl gene (Callus and Mathey-Prevot,
2002; Rawlings et al., 2004). HumanSOCS4/SOCS5 share
90% sequence identity within the SH2 domain and 72%
with the SOCS36E SH2 domain and conserved function
in humans has been suggested by two recent studies
showing SOCS4/SOCS5 regulation of EGFR signaling
(Kario et al., 2005; Nicholson et al., 2005). In accordance
with the classical SOCS model, EGF-induced expression
of SOCS4 andSOCS5 reducedSTAT3 signaling as a result
of increased EGFR degradation. Expression of other
SOCS family members did not produce this effect.
However, a genomic screen of recombinant SH2 do-
mains failed to identify a significant SOCS-EGFR interac-
tion (Jones et al., 2006) and further characterization of this
interaction in vitro is currently lacking. Notably, 13 of the
14 SH2 domains tested from the STAT and SOCS families
were expressed in inclusion bodies and refolding had lim-
ited success (Jones et al., 2006). We recently presented
a general strategy to overcome this problem by coex-
pressing a multidomain SOCS construct with its constitu-
tive binding partners ElonginB and ElonginC (Bullock
et al., 2006). Using this approach, we were able to deter-
mine the domain organization of a SOCS family member
with the crystal structure of the SOCS2-ElonginC-Elon-
ginB complex (Bullock et al., 2006). The structure defines
a prototypical SOCS box ubiquitin ligase. First, the SOCS
box is conservedwith the BC box of VHL, which also binds
ElonginB/ElonginC and targets hypoxia-inducible factor
(HIF-1a) for proteasomal degradation (Stebbins et al.,
1999). Second, the positions of the substrate binding sites
in SOCS2 (SH2) and VHL (b-domain), which are function-
ally unrelated, are superimposable within the ternary com-
plexes, suggesting a common spatial requirement for
ubiquitination.
An essential requirement of this model is a stable inter-
face between the substrate binding domain and SOCS
box. In SOCS2, the three helices of the SOCS box make
no contact with the SH2 domain, and instead the C termi-
nus occupies the interdomain interface, allowing the car-
boxy group to participate in a critical hydrogen-bonding
network. This packing precludes C-terminal extensions
and explains the strictly conserved length of the C termi-
nus in CIS and SOCS1–SOCS3. However, this solution
raised the question how members of the extended
SOCS family would function and interact with elongins.
The ancestral SOCS proteins and their human orthologs
cannot adopt the same stable C-terminal packing since
SOCS4, SOCS5, and SOCS7 show variable C-terminal
extensions, while SOCS6 has a two residue truncation.
To determine the alternative domain organization of this
second SOCS subfamily and to understand the structural
basis for EGFR degradation, we determined the structure1494 Structure 15, 1493–1504, November 2007 ª2007 Elsevierof the SOCS4-ElonginB/C complex. A novel SOCS box in-
terface is revealed that frees the extended C terminus to
form a new interface stabilizing the N-terminal domain.
To address the limited knowledge of SOCS substrate
specificity we also characterized the binding of SOCS2
and SOCS4 to a degenerate peptide library as well as to
known SOCS target sites. We observed strong submicro-
molar binding of SOCS4 to phosphotyrosine sites with +1
isoleucine including EGFR pY1092 providing a molecular
mechanism for SOCS4 inhibition of STAT3 signaling as
well as EGFR degradation.
RESULTS
Human SOCS4was coexpressed with its binding partners
ElonginB and ElonginC in E. coli. The crystal structure of
the corresponding SOCS4-ElonginC-ElonginB ternary com-
plex was solved by molecular replacement and was re-
fined to 2.5 A˚ resolution (see Table 1 for data collection
and refinement statistics). Comparison of the SOCS2
(Bullock et al., 2006) and SOCS4 ternary complexes
revealed a common tripartite domain structure with an
N-terminal extended SH2 subdomain (ESS helix) that sta-
bilizes the central SH2 domain and a C-terminal SOCS
box that mediates a conserved four helix bundle interac-
tion with ElonginC (Figure 1). SOCS4 has a two-residue
insertion in this motif that extends the H2 310-helix found
in SOCS2. The C terminus of ElonginB packs beneath
this helix and completes its hydrophobic packing.
The Extended SH2 Domain Is a Conserved
Structural Element
SOCS proteins possess a highly variable N-terminal do-
main with no homology to known structural domains.
Mutagenesis studies identified an ESS helix in CIS and
SOCS1–SOCS3 that was critical for high affinity SH2 sub-
strate interactions (Yasukawa et al., 1999) and an addi-
tional N-terminal kinase inhibitory region (KIR domain) re-
sembling a JAK pseudosubstrate in SOCS1 and SOCS3
(Yasukawa et al., 1999; Nicholson et al., 1999). In the
structure of SOCS4, the ESS forms a single helix N-termi-
nal to the SH2 domain that packs behind the BC and DE b-
hairpins. This structure has not been described previously
for SOCS4–SOCS7 but appears to be a general feature
of the SOCS SH2 domain. Notably, the ESS and SH2
domains are superimposable as a single structural motif
in SOCS2 (Bullock et al., 2006), SOCS3 (Babon et al.,
2006; Bergamin et al., 2006), and SOCS4 (Figure 2). These
extended SH2 domains are stabilized by a conserved hy-
drophobic surface on the ESS that buries residues from
bA, bB, bC, bE, and aA. SOCS4 is distinguished by a pro-
line insertion that restricts the length of the ESS to half that
of the SOCS2 and SOCS3 helices and corresponds to
the loss of structure in the equivalent KIR domain region.
Interestingly, this shorter ESS is highly similar to the N-ter-
minal helices associated with the Cbl (aN) (Meng et al.,
1999) and STAT family SH2 domains (e.g., STAT1 a11)
(Chen et al., 1998) which fulfill a similar packing role.Ltd All rights reserved
Structure
Structure of the SOCS4-ElonginB/C Ternary ComplexTable 1. Crystallographic Data and Refinement Statistics
Data Collection SOCS4-ElonginC-ElonginB
Space group H3
Cell dimensions (A˚) a = 154.770, b = 154.770, c = 67.909
Resolution (A˚) 2.55
Total obs. (unique, red.) 56643 (19724, 2.71)
Completeness (outer shella) 99.7% (97.9%)
Rmerge (outer shell
a) 0.13 (0.48)
I/s (outer shella) 9.14 (2.0)
Refinement
Rwork (Rfree
b) (%) 17.4 (22.3)
Protein atoms (water) 2806 (113)
Hetero groups: ethylene glycol, Na+, Cl
Rmsd bond length (A˚) 0.013
Rmsd bond angle (o) 1.438
Average B Factor (A˚2)
Protein atoms 29.8 (SOCS4) 34.2 (El.B) 32.1 (El.C)
Solvent atoms 26.1
Other 53.7
Ramachandran SOCS4 ElonginB ElonginC
Allowed (%) 100 96.7 100
Generously allowed (%) 0 2.2 0
Dissallowed (%) 0 1.1 0
aOuter shell 2.65–2.55 A˚.
bUsing randomly selected 5% of data.The SOCS4 SH2 domain adopts a canonical SH2 fold
with the substrate pocket positioned on the opposite
face to the ESS. SH2 ligands bind across the central bD
strand which separates the phosphotyrosine (pY) pocket
from the hydrophobic +3 site where ligand specificity is
typically determined. The overall structure of the phos-
photyrosine pocket in SOCS4 is similar to SOCS2 and
SOCS3, but the pocket side chains adopt different roles
binding the phosphotyrosine ligand (Figure 2A). CIS and
SOCS1–SOCS3 are characterized by the absence of the
common SH2 aA2 arginine, and bind phosphotyrosine
instead with two conserved arginine residues at the
bB5 and bD6 positions (Figure 2B) (SOCS3 R71 and
R94, respectively). The SOCS4 SH2 domain harbours a
lysine residue at the aA2 position, which also ligates
the phosphotyrosine in STAT1 (Mao et al., 2005). The
SOCS4 bD6 arginine (R334) is also distinguished by
forming a hydrogen bond network with Q315 and E336
that removes the arginine side chain from the phospho-
tyrosine binding site. However, the bD6 interaction is
likely to be substituted by Q315 N3, which occupies
the same position as R344 Nh in the SOCS2/SOCS3
structures (Figure 2A). Interestingly, the SOCS4 substrate
binding pocket is occupied by residues from the N-termi-
nal tag sequence of a crystallographic neighbor (Fig-Structure 15, 1493–150ure 2B). The main chain follows closely the path of the
bound gp130 peptide in the SOCS3 SH2 structure (Ba-
bon et al., 2006; Bergamin et al., 2006) but is oriented
in an antiparallel fashion. Nonetheless, expected sub-
strate interactions are formed by a phenylalanine that
mimics the phosphotyrosine and a leucine residue that
fills the hydrophobic +3 site.
SOCS SH2 domains show the greatest diversity in the
conformations of the EF and BG loops that frame the hy-
drophobic +3 pocket, a region that shares little sequence
identity between SOCS family members. The SOCS4 EF
loop is three residues shorter than SOCS2/SOCS3 and
arches away from the substrate pocket. In contrast, the
longer EF loop in SOCS3 folds above the substrate pocket
and makes significant contact with the bound gp130 pep-
tide to contribute to the unusually high affinity of this inter-
action (Babon et al., 2006; Bergamin et al., 2006). The
SOCS4 BG loop is well defined in contrast to the unstruc-
tured insertions that follow the aB helix in SOCS2 and
SOCS3. In addition, the SOCS4 BG loop folds markedly
inwards compressing the +3 site (Figures 2A and 2B).
Overall, the binding surface of SOCS4 is distinguished
by a strongly negative electrostatic surface potential in
comparison to the mainly basic SOCS2 and SOCS3
(Figure 2C).4, November 2007 ª2007 Elsevier Ltd All rights reserved 1495
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Structure of the SOCS4-ElonginB/C Ternary ComplexFigure 1. Structure of the SOCS4-ElonginC-ElonginB Ternary Complex and Structure-Based Sequence Alignment
(A) The different SOCS4 domains are highlighted by color with the N-terminal ESS shown blue, the SH2 shown orange, and the SOCS box shown red.
A structured region from the N-terminal hexahistidine tag that was protected from proteolytic cleavage in solution is colored gray. The other complex
components ElonginC and ElonginB are colored yellow and green, respectively.
(B) Secondary structure elements in SOCS4 are shown above the sequence alignment. Structure-determined residues from SOCS2–SOCS4 are
shown in bold; unstructured insertions and homologous SOCS sequences are gray, while conserved residues are boxed. An asterisk marks the
insertion of R383 in the SOCS4 hinge, which stabilizes the SOCS4 domain organization. This and other interface residues are highlighted by different
colors in the alignment.Domain Organization Defines a Second Structural
Subclass of SOCS Family Members
In SOCS2, the C terminus is buried in the core of the struc-
ture where it stabilizes the interface between the SH2
domain and the SOCS box (Bullock et al., 2006). A 14
residue C-terminal extension in SOCS4 prevents these in-
teractions resulting in an alternative domain organization.
Interestingly, the SOCS4 ESS helix replaces the SOCS2 C
terminus in the domain interface (Figures 3A and 3B). This
is accomplished by rotation of 80 of the SH2 domain with
respect to SOCS2 (calculated by using the DynDom
server [Hayward and Berendsen, 1998]).
An overlay of the two SOCS box-Elongin structures
shows excellent superimposition up to a conserved threo-
nine at the N-terminus of the SOCS box (T158 and T384 in
SOCS2 and SOCS4, respectively) (Figures 3C and 3D). In
both structures, this residue forms a hinge point where the
backbone kinks tomeet the SH2 domain. Significantly, the
SOCS4 hinge has an insertion of R383, which redirects the
path of themain chain. The alternative conformation is sta-
bilized by the R383 side chain, which is buried in a hydro-
phobic pocket between the N-termini of the SH2 domain
(bA residues Y287 and W288) and SOCS box (F385 and
F387). The guanidinium group binds these structures to-
gether with hydrogen bonds to the main chain oxygens
of Y287 and F385 (Figure 3B). The two phenylalanine
side chains appear too large to be accommodated in
a SOCS2-like conformation.
The main function of the C-terminal SOCS box exten-
sion seems to be the interaction with the SOCS4 N-termi-1496 Structure 15, 1493–1504, November 2007 ª2007 Elsevienus. These sequences are stabilized in an antiparallel
b sheet that packs behind the SH2 DE loop (Figure 3A).
The C-terminal residues of SOCS5–SOCS7 are more sim-
ilar to SOCS4 than CIS1/SOCS1–SOCS3 and are also ex-
pected to pack on the surface of the SH2 domain. In par-
ticular Y424, which occupies the hydrophobic core of the
C-terminal packing and hydrogen bonds to the DE loop, is
strictly conserved in SOCS4–SOCS7, but this residue is
not present in CIS1/SOCS1–3, giving additional support
for two distinct domain packing interactions in SOCS fam-
ily members.
SOCS4 Is a High Affinity Binding Partner
for EGFR pY1092
SOCS4 has been implicated in the regulation of EGFR
degradation (Kario et al., 2005; Nicholson et al., 2005),
but a direct interaction has not been demonstrated, and
to date the substrate binding sites for SOCS4 have not
been defined. To further delineate the activity of different
SOCS family members, we used an oriented peptide array
library (OPAL) (Rodriguez et al., 2004) to determine the se-
quence preferences of SOCS2 and SOCS4 and compared
these data to previous analyses of SOCS3 (De Souza
et al., 2002), SOCS6 (Krebs et al., 2002), and SOCS7
(Krebs et al., 2002) (Figure 4). The arrays presented repre-
sent, to our knowledge, the first study that used function-
ally expressed SOCS protein that has not required refold-
ing. In common with most SH2 domains, the SOCS family
exhibit sequence preferences at positions C-terminal to
the phosphotyrosine and belong to a SH2 class selectiver Ltd All rights reserved
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Structure of the SOCS4-ElonginB/C Ternary ComplexFigure 2. Structural Comparison of the SH2 Substrate Pockets in SOCS2, SOCS3, and SOCS4
(A) Overlay of the crystal structures of the SOCS4 SH2 (orange) and the SOCS2 SH2 (blue, PDB code: 2C9W). The binding site of the phosphotyrosine
moiety in SOCS2 is indicated by the presence of a bound sulfate ion. SOCS4 residues at this site are shown in ball-and-stick representation with their
potential hydrogen bonding.
(B) Overlay of the crystal structures of the SOCS4 SH2 (orange) and the murine SOCS3 gp130 complex (blue, PDB code: 2HMH). The phosphotyr-
osine and three C-terminal residues from the murine gp130-derived peptide are colored green. N-terminal tag residues from a crystallographic
SOCS4 neighbor occupy the same SH2 pocket in the SOCS4 structure forming substrate mimetic interactions and are colored yellow.
(C) Surface representation of the SH2 substrate pocket in SOCS2, SOCS3, and SOCS4 colored by electrostatic potential. The bound sulfate ion iden-
tifies the phosphotyrosine binding site in SOCS2 (left). The gp130 peptide is shown in complex with SOCS3 (center) and docked onto the SOCS4
surface (right) by the overlay of the two structures (for SOCS4 only the gp130 residues corresponding to the pY1 to pY+3 positions are shown).for hydrophobic residues at the +1 and +3 positions.
SOCS2 and SOCS4 show strong preference for isoleu-
cine, leucine, and valine at both positions with the exclu-
sion of leucine at +3 (Figure 4).
However, there are notable differences in substrate
recognition between SOCS2/SOCS4 and classic SH2 do-
mains like Src. In addition to residues C-terminal to the
phosphotyrosine, SOCS2 and SOCS4 have preferred
amino acids at positions N-terminal to the phosphotyro-
sine. For SOCS2, isoleucine, leucine and valine at the 3
and aspartate at the 1 position are selected, respec-
tively. The SOCS2 SH2 consensus motif (Figure 4) is con-
sistent with its binding to the pY595 site in growth hormone
receptor (GHR), which is the suggested physiologicalStructure 15, 1493–1504target site for SOCS2 (Greenhalgh et al., 2005). Namely,
the GHR pY595 peptide contains the preferred valine, as-
partate, and isoleucine respectively at the 3, 1, and
+3 positions, while the +1 threonine is a secondary selec-
tion site. In contrast, SOCS4 shows a strong preference
for b-branched amino acids isoleucine, leucine, and valine
at the +1 position and slight preference for isoleucine, leu-
cine, and valine at the 3 and alanine at the 1 position.
The selection against aspartate and glutamate at the +1
to +4 positions is consistent with the negative electrostatic
surface potential of the SOCS4 substrate pocket and is
a further determinant of SOCS4 specificity.
To date, only a limited number of SOCS target sites
have been mapped, and these are largely restricted to, November 2007 ª2007 Elsevier Ltd All rights reserved 1497
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Structure of the SOCS4-ElonginB/C Ternary ComplexFigure 3. Alternative Domain Organization in the SOCS2 and SOCS4 Ternary Complexes
(A) Comparison of the SOCS2-ElonginB/ElonginC and SOCS4-ElonginB/ElonginC structures highlighting the switch in packing between the SOCS2/
SOCS4 C terminus and the N-terminal ESS helix (colored as in Figure 1).
(B) Molecular interactions stabilizing the domain organization in SOCS4.
(C) Structural overlay of the SOCS2 and SOCS4 SOCS box showing an 80 rotation of the SOCS4 SH2 domain relative to the SOCS2 SH2. The po-
sitions of the SOCS2 and SOCS4phosphotyrosine pockets are indicated by a SOCS2-bound sulfate ion and a SOCS4-bound phosphotyrosine (mod-
eled as in Figure 2). For clarity, the SOCS2 ESS is omitted and only the N-terminal half of each SH2 domain is shown. An asterisk denotes the position
of the hinge point for rotation which occurs at R383/T384 in SOCS4.
(D) Structural overlay of the SOCS2 and SOCS4SH2domains showing the alternative packing sites for the respective SOCS box domains on opposite
faces of the ESS and SH2. The SOCS2-bound sulfate ion indicates the position of the SH2 phosphotyrosine pocket.substrates of CIS/SOCS1–SOCS3. We determined bind-
ing affinities for these previously identified sites in solution
by using isothermal titration calorimetry (ITC). In addition,
we analyzed the known target sites associated with EGFR
degradation. Consistent with the OPAL data, SOCS2 was
highly selective for the preferred growth hormone receptor
site pY595 and no other targets were identified of similar af-
finity (Table 2). SOCS4 was found to bind to EGFR pY1092
(KD = 0.5 mM) with an affinity comparable to the known
physiological ligand Grb2 (KD = 0.4–0.7 mM) (Chook
et al., 1996; Lemmon et al., 1994). EGFR pY1092 contains
a favorable valine at the3 position and the preferred iso-
leucine at the +1 position, consistent with the determined
SOCS4 SH2 consensus. In contrast, SOCS4 showed little1498 Structure 15, 1493–1504, November 2007 ª2007 Elsevieraffinity for the Cbl target site on EGFR pY1069 (KD > 10 mM).
Interestingly, SOCS4 also bound JAK2 pY1007 and KIT
pY568 with an affinity below 3 mM, suggesting functional
similarity with Drosophila SOCS36E (Callus and Mathey-
Prevot, 2002; Rawlings et al., 2004) and human SOCS6
(Bayle et al., 2004), respectively. This affinity is similar to
the binding of Grb7 to ErbB2 (KD = 2.3 mM) (Ivancic
et al., 2005). Other target sites bound with weaker affinity,
particularly those with the loss of either the +1 or +3
hydrophobic position (Table 2). Overall, SOCS4-peptide
interactions were characterized by a considerably larger
enthalpic contribution to binding than SOCS2 suggesting
the formation of a larger number of favorable polar
contacts.Ltd All rights reserved
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Structure of the SOCS4-ElonginB/C Ternary ComplexFigure 4. SOCS4 Is a High Affinity Binding Partner for EGFR pY1092
(A) OPAL membranes showing the substrate binding specificity of SOCS2 (top) and SOCS4 (below). Bound GST-SOCS-ElonginB/C complexes were
detected by using anti-GST-HRP antibody. The large surface area of the SOCS complexesmay contribute to the strong background binding to R/F/Y/
W. Consequently, the preference for these residues is not considered here.
(B) Comparison of the determined SOCS consensus recognition sequences and their suggested physiological targets. By sequence and functional
similarity, the SOCS family members can be grouped into pairs as shown. Brackets ([ ]) indicate preferred amino acids, whereas gray braces ({ }) in-
dicate nonpreferred amino acids. X denotes any amino acid, and F denotes any hydrophobic residue. y, De Souza et al. (2002); z, Krebs et al. (2002);
U, Rodriguez et al. (2004); x, Wiederkehr-Adam et al. (2003); *, Barber et al. (2001).
(C) The SOCS4 binding affinity for EGFR pY1092 was determined by ITC (KD = 0.5 mM). Data for peptide titrations into SOCS4 are colored black, while
data from a control experiment are colored blue and offset for clarity in the top panel.
(D) Structural model of the SOCS4-EGFR complex. The complex was modeled by using the homologous SOCS3-gp130 crystal structure (PDB code:
2HMH) as a template peptide for EGFR, and side chains were optimized by using ICM-PRO (Abagyan et al., 1994). The SOCS4 F373 side chain (BG
loop) is solvent exposed and was relaxed to open the +4 position. A complete model for the SOCS2-GHR complex could not be built because in the
apo SOCS2 structure, the flexible EF loop is folded into the +2 site to block the path of the peptide. The preferred 1 aspartate can pack between
SOCS2 K59 (aA6) and T93 (bD3) to maximize its hydrogen bonding potential and similar residues are present in CIS (R93 and T127). The SOCS2
hydrophobic selection at positions C-terminal to the phosphotyrosine can be understood from the presence of leucine at bD5, bE4, and BG3 (Bullock
et al., 2006).Structure 15, 1493–1504, November 2007 ª2007 Elsevier Ltd All rights reserved 1499
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Structure of the SOCS4-ElonginB/C Ternary ComplexTable 2. ITC Binding Data for Phosphotyrosine Peptides
Peptide KD (mM) KB 3 10
5 (M1) DHobs (kcal/mol) TDS (kcal/mol) DG (kcal/mol) Na
SOCS2/ElonginBC
EGFR pY1069 >15
EGFR pY1092 >15
EpoR pY402b 7.1 1.42 ± 0.27 3.69 ± 0.46 3.34 7.03 0.73
GHR pY487 11.3 0.89 ± 0.64 1.49 ± 0.76 5.16 6.65 1.05
GHR pY595b 1.6 6.08 ± 1.03 3.35 ± 0.11 4.54 7.89 1.22
gp130 pY759c >15
JAK2 pY1007 8.1 1.23 ± 0.34 3.62 ± 0.63 3.22 6.84 0.89
KIT pY568 8.3 1.20 ± 0.23 3.62 ± 0.38 3.19 6.81 1.12
LeptinR pY1077 >15
Peptide pYINP >15
SOCS4/ElonginBC
EGFR pY1069 11.6 0.86 ± 0.12 13.0 ± 2.0 6.35 6.64 0.95
EGFR pY1092 0.5 19.0 ± 1.0 10.8 ± 0.1 2.36 8.42 1.00
EpoR pY402 7.7 1.30 ± 0.16 14.5 ± 1.3 7.59 6.86 0.71
GHR pY487 5.1 1.96 ± 0.11 10.6 ± 0.2 3.49 7.10 1.18
GHR pY595 6.1 1.63 ± 0.18 10.1 ± 0.5 3.08 6.99 0.96
gp130 pY759c 7.1 1.41 ± 0.17 7.08 ± 0.40 0.17 6.91 1.12
JAK2 pY1007 2.9 3.43 ± 0.25 11.3 ± 0.2 3.87 7.41 1.00
KIT pY568 2.9 3.43 ± 0.24 7.03 ± 0.12 0.40 7.43 1.29
LeptinR pY1077 5.5 1.82 ± 0.13 7.69 ± 0.24 0.63 7.06 0.96
Peptide pYINP 1.1 9.40 ± 0.47 12.2 ± 0.1 4.16 8.03 0.79
a Stoichiometry and curve fitting errors determined from a single binding site model with the Microcal Origin software.
b Bullock et al., 2006.
c Note the human numbering differs frommurine gp130 pY757. The preferred substrate peptide is shown in bold. ITC binding curves
for these data are shown in Figure S1.A structural model for the SOCS4-EGFR interaction was
derived to understand the observed substrate specificity.
The SOCS4 crystal packing (Figure 2B) supports a classic
extended bindingmode similar to the SOCS3-gp130 com-
plex (Babon et al., 2006; Bergamin et al., 2006). SOCS4
has a highly unusual bD5 alanine (a position that frequently
correlates with specificity (Songyang and Cantley, 1995)
and consequently contains a substrate pocket lined with
large hydrophobic side chains that fill the vacant packing.
Here, the EGFR +1 isoleucine occupies a hydrophobic
pocket formed between L331 (bD3) and F324, consistent
with its primary selection inOPAL (Figure 4D). The BG loop
packing compresses the substrate pocket so that EGFR
makes close contact with the EF loop where the +2 aspar-
agine can hydrogen bond to the backbone oxygen of
F344. The +3 glutamine can extend to the back of the +3
pocket to interact with Y364 and E374. TheOPAL selectiv-
ity for [IVSTG] at this position reflects the relatively small
pocket volume and the larger glutamine residue may in-
duce limited conformational strain. Overall, the SOCS4
specificity and binding mode is similar to the SHP2-IRS1
complex structure (PDB code: 1AYB) in which the ex-1500 Structure 15, 1493–1504, November 2007 ª2007 Elseviertended IRS1 peptide contains a pYVNI sequence (Lee
et al., 1994). The insulin receptor substrate protein family
is a recognized target for SOCS1/SOCS3 (Rui et al.,
2002) and SOCS6/SOCS7 (Krebs et al., 2002), and the
close match with the SOCS4 consensus suggests that
SOCS4may also target members of this important protein
family.
DISCUSSION
The SOCS family members SOCS4–SOCS7 were origi-
nally identified by their conserved SOCS box, an adaptor
motif comprising three helices that associates substrate
binding domains, such as the SOCS SH2 domain, ankryin,
and WD40 repeats, with the ubiquitin ligase components
ElonginC and ElonginB (Hilton et al., 1998). The crystal
structures of the SOCS2 and SOCS4-ElonginB/ElonginC
complexes highlight an important evolutionary divergence
between the SOCS box of SOCS4–SOCS7 and that of CIS
and SOCS1–SOCS3 (Bullock et al., 2006). The two fami-
lies make alternative use of N- and C-terminal sequences
to provide the SH2-SOCS box interdomain interface. ByLtd All rights reserved
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Structure of the SOCS4-ElonginB/C Ternary ComplexFigure 5. SOCS4 Interdomain Packing Is
Similar to Cbl and STAT Family Proteins
(A) The Cbl aN helix (cyan) is structurally equiv-
alent to the SOCS4 ESS (blue), having similar
length and position. This structure connects
the Cbl SH2 (pale yellow) and EF-hand (purple)
domains and adopts a similar position to the
bound helical peptides in calmodulin struc-
tures. Further, the Cbl helices aE1, aF2, and
aF1 are placed similarly to SOCS box H2, H3
(red), and ElonginC H4 (green), respectively, al-
though they show alternative topology. The
SOCS4 SH2 domain is colored orange.
(B) The packing in Cbl has been likened to the STAT family in which the linker domain fulfills an equivalent packing role to the Cbl EF hand (Meng et al.,
1999). Overlay of the STAT1 (pale yellow) and SOCS4 (orange) SH2 domains reveals structural similarity between the STAT1 a11 (cyan) and a7 helices
(purple) and the SOCS4 ESS (blue) and H1 (red), respectively.burying the C terminus in this interface the SOCS2-type
domain organization partially exposes the ESS providing
greater accessibility for the SOCS1/SOCS3 KIR domain.
In contrast, SOCS4 buries the ESS between the SOCS
box and SH2 domain to fulfill an equivalent packing role
to the SOCS2 C terminus. The function of the SOCS4 C
terminus is then redefined to stabilizing a new interface
with the N terminus, which packs as an antiparallel b sheet
behind the SH2 DE loop. The new domain organization
correlates with the presence of a greatly expanded N-ter-
minal domain, consisting of 300–400 residues, which is
found in SOCS4–SOCS7, but not in other SOCS family
members. This region remains to be structurally and func-
tionally characterized. It is highly variable between the
SOCS members and shows no similarity to domains of
known three-dimensional structure.
The SOCS box mediates further assembly with Cul5
and Rbx2 to form a RING-type E3 ubiquitin-ligase (Ka-
mura et al., 1998, 2004). These complexes are proposed
to function as stable scaffolds that present bound
substrate to E2 enzymes with the correct distance and
orientation for efficient ubiquitin transfer (Petroski and
Deshaies, 2005; Zheng et al., 2002). An unexpected fea-
ture of the SOCS4 rearrangement is an 80 rotation of
the ESS/SH2 domain with respect to SOCS2. This rotation
does not affect the overall placement of the SH2 domain
within the ternary complex, which is conserved with the
substrate-binding domains of other cullin-dependent ubiq-
uitin ligases. In particular, structural models for F box (Hao
et al., 2007) andSOCSbox (Figure S2, see the Supplemen-
tal Data available with this article online) complexes show
asimilar rangeof substrate peptide orientations suggesting
that SOCS4 retains a viable scaffold to support E3 ligase
activity. The new domain arrangement in SOCS4 also pro-
vides an interesting parallel with the packing found in the
structures of Cbl (Meng et al., 1999) and STAT (Chen
et al., 1998) family members revealing a common mecha-
nism to stabilize SH2 structure. The SOCS4 packing is
mostclosely related to the c-CblSH2andEFhanddomains
(Figure 5). This similarity is intriguing given the interaction of
both proteins with EGFR. This common arrangement
appears to provide amore stable and rigid packing solution
than the alternative SOCS2 structure, potentially reflecting
thegreater selection for rapid inductionanddegradation re-Structure 15, 1493–150sponses in the CIS/SOCS1–SOCS3 subfamily (for exam-
ple, phosphorylation of the SOCS3 interface Y221 induces
its degradation).
Cellular studies have shown induction of SOCS4 and
SOCS5 upon EGF stimulation and subsequent SOCS
box-dependent degradation of EGFR and inhibition of
the mitogenic signal that is independent of Cbl (Kario
et al., 2005; Nicholson et al., 2005). SOCS5 shows 84%
sequence identity with SOCS4 within the region covered
by this structure and has conserved residues at key sites
determining substrate binding and domain orientation.
The Drosophila ortholog SOCS36E shows similar conser-
vation, and together these SOCS proteins form a tight
subgroup within the SOCS family. SOCS5 immunoprecip-
itation of EGFR was inhibited by SH2 mutation, but the
molecular basis for this interaction was not determined.
We identified a high affinity binding site for SOCS4 at
tyrosine 1092 in EGFR (KD = 0.5 mM). This position is
well characterized as an EGFR autophosphorylation site
and is targeted with similar affinity by the SH2 domain of
Grb2, which transduces EGF signaling. Immunoprecipita-
tion studies supported a second constitutive EGFR inter-
action site within the SOCS5 N-terminal domain (Nichol-
son et al., 2005), and it is interesting to note that the
N-terminus packs alongside the DE loop by the +2 pocket
in the SOCS4 structure. This bidentate recognition would
be reminiscent of the interaction of SOCS1 with JAK ki-
nases, which also involves the KIR domain in addition to
the SH2 domain. The Cbl and STAT SH2-substrate inter-
actions also involve an extended binding interface with
a second interaction domain (Mao et al., 2005; Meng
et al., 1999). Such interaction is likely to further increase
the SOCS-EGFR affinity as observed for the physiological
Grb2/mSos1-EGFR complex (KD = 0.3 mM) (Chook et al.,
1996). SOCS5 function may differ from SOCS4 primarily
by a further N-terminal extension that binds the box1
domain of the IL-4 receptor (IL-4Ra) to regulate STAT6
signaling in Th2 cell differentiation (Seki et al., 2002).
Multiple ubiquitin ligases have been identified for the
ErbB family in addition to Cbl, which targets EGFR directly
at pY1069 (KD = 0.4 mM) or through Grb2 at pY
1092, for ex-
ample CHIP (ErbB2) (Xu et al., 2002), LNX1 (ErbB2) (Young
et al., 2005), Nrdp1 (ErbB3) (Qiu and Goldberg, 2002), and
AIP4/Itch (ErbB4) (Omerovic et al., 2007). Potentially, as4, November 2007 ª2007 Elsevier Ltd All rights reserved 1501
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may provide further regulation with alternative spatial
and temporal control. Direct demonstration of SOCS4/
SOCS5 ubiquitin ligase activity remains to be proven,
but SOCS4/SOCS5 binding at EGFR pY1092 would never-
theless also compete directly with STAT3 consistent with
reduced STAT3 signaling in cellular transfection studies
(Kario et al., 2005). SOCS5 also reduced the levels of
ErbB2 and ErbB4 (Kario et al., 2005), which have homolo-
gous sites to EGFR 1092 (pYINQ), for example pYVNQ
(ErbB2) and pYLNP (ErbB4), while this motif is absent in
ErbB3. From our existing peptide panel, we indeed de-
tected tight SOCS4 binding to a similar pYINP site
(KD = 1.1 mM) (Table 2). In total there are 89 cytosolic tyro-
sines in the ErbB family, of which approximately half have
been linked to signaling, with six Grb2 binding sites iden-
tified in EGFR alone (Schulze et al., 2005). Given its appar-
ent relaxed specificity, SOCS4 appears similarly compat-
ible with additional interaction sites, for example binding
to EGFR pY1138 (pYLNT) would also be predicted. Further
studies are required to delineate these activities and the
physiological SOCS4 response.
Interestingly, SOCS2 is also suggested to downregulate
STAT5b signaling from EGFR without degradation (Gold-
shmit et al., 2004), while SOCS1 and SOCS3 are reported
to downregulate STAT1-EGFR signaling (Xia et al., 2002).
Our OPAL specificity data support the strong association
between SOCS2 and STAT5 target recognition sites, but
do not suggest a simple correlation of one SOCS inhibitor
regulating one STAT family member. Instead, we observe
overlapping SOCS/STAT (and SHP2) sequence prefer-
ences rather than direct similarity. For example, in the
EGFR Y1092 recognition site SOCS4 is selective for +1 iso-
leucine, whereas STAT3 is selective for +3 glutamine (Wie-
derkehr-Adam et al., 2003). Furthermore, Grb2 targets the
same site with a b-hairpin binding mode that confers
specificity for +2 asparagine (Songyang et al., 1993).
These preferences highlight an important signaling control
mechanism. Since the interactome of all three proteins is
distinct, SOCS4 may inhibit a specific subset of STAT3
sites without perturbing other STAT3 targets that should
remain active.
We also detected low micromolar binding of SOCS4 to
JAK2 pY1007 consistent with studies on SOCS36E in Dro-
sophila (Callus and Mathey-Prevot, 2002; Rawlings et al.,
2004). Previous work has noted a degree of sequence
conservation between the KIR domain of SOCS1/
SOCS3 and the equivalent region of SOCS4/SOCS5
(and SOCS36E) (Narazaki et al., 1998; Nicholson et al.,
1999). The SOCS1 KIR domain has activity against both
the JAK2 and EGFR kinase domains (Waiboci et al.,
2007), but similar SOCS4/SOCS5 activity has not been
demonstrated due to their low expression levels in these
studies (Nicholson et al., 1999). While these experiments
merit further investigation, the data presented here reveal
a different KIR structural environment in SOCS4/SOCS5
and provide an alternative mechanism for the observed
SOCS4/SOCS5 inhibition of EGFR through binding at
pY1092. These structural and specificity data open new op-1502 Structure 15, 1493–1504, November 2007 ª2007 Elsevier Lportunities to rapidly characterize the extended SOCS4–
SOCS7 subfamily further.
EXPERIMENTAL PROCEDURES
Protein Expression and Crystallization
Human SOCS4 (amino acids 274–437), ElonginC (amino acids 17–
112), and ElonginB were coexpressed in BL21(DE3) from the plasmids
pNIC-SOCS4 and pACYCDUET-ElCB. Ternary complex was purified
by nickel-affinity, size-exclusion, and anion-exchange chromatogra-
phy and concentrated to 11 mg/ml in 50 mM HEPES (pH 7.5), 250
mM NaCl, 10 mM DTT. The N-terminal hexahistidine tag was buried
in the structure and therefore protected from cleavage. The protein
complex was judged to be at least 95% pure by SDS PAGE, and the
correct molecular weight of all three proteins was confirmed by using
liquid chromatography electrospray ionization mass spectrometry.
Crystals were grown at 4C in 150 nl sitting drops by using a mother
liquor of 10% PEG6000 and 2M NaCl.
Structure Determination
SOCS4 diffraction data were collected on a frozen crystal (100 K) at the
Swiss Light Source Beamline 10 (Villigen, Switzerland). Images were
indexed and integrated with MOSFLM and scaled with SCALA within
the CCP4 program suite (CCP4, 1994). The structure was solved by
molecular replacement with the SOCS2-ElonginB/ElonginC complex
(PDB code: 2C9W) as a searchmodel with the program PHASER (Stor-
oni et al., 2004). Iterative rounds of rigid-body refinement and re-
strained refinement with TLS (translation-libration-screw) against max-
imum likelihood targets were interspersed by manual rebuilding of the
model with COOT (Emsley and Cowtan, 2004) and XFIT/XTALVIEW
(McRee, 1999; Murshudov et al., 1997). Figures were prepared with
PYMOL (DeLano, 2002) and ICM-PRO (Abagyan et al., 1994).
Isothermal Titration Calorimetry
Experiments were carried out in 50mMHEPES (pH 7.5), 150mMNaCl,
1 mM DTT at 20C, injecting 0.3–0.4 mM peptide solution into 15 mM
protein solution. Blank titrations were subtracted from binding data,
and data were processed by using ORIGIN software provided with
the instrument. Peptides: EGFR pY1069 LQR(pY)SSDPTGA; EGFR
pY1092 PVPE(pY)INQSVP; EpoR pY402 ASFE(pY)TILDPS; GHR
pY487 NIDF(pY)AQVSDIT; GHR pY595 PVPD(pY)TSIHIV; gp130 pY759
STVQ(p)YSTVVHS; JAK2 pY1007 QDKE(pY)YKVKEPG; KIT pY568
NGNN(pY)VYIDPT; LeptinR pY1077 KSVC(pY)LGVTSVN; Peptide
pYINP TLDN(pY)INPDAA.
Determination of SOCS Substrate Binding Specificity
Using OPAL
Oriented peptide array libraries (OPAL) were synthesized and screened
as previously described (Rodriguez et al., 2004). Briefly, the synthe-
sized OPAL has the sequence AXXXX[pY]XXXXA, where X is a mixture
of 19 amino acids (except Cys). TheOPALmembranewas first blocked
with 5% milk in TBST (0.1M Tris-HCl [pH 7.4], 150 mM NaCl, 0.1%
Tween20) for one and half hours. GST-SOCS-ElonginB/ElonginC com-
plex fusion proteins (1 mg) were incubated with anti-GST-HRP (0.2 mg,
Amersham) for 1 hr and then added to the array membrane at a final
concentration of 0.5 mg/ml for 1 hr. The array membrane was subse-
quently washed three times with TBST for 10min, and positive peptide
spots were visualized by ECL.
Supplemental Data
Supplemental Data include Figure S1 (ITC binding curves) and
Figure S2 (models of SOCS E3 ligases) and are available at http://
www.structure.org/cgi/full/content/15/11/1493/DC1/.td All rights reserved
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